Philip Morris
Prevalence of Tobacco Dependence and Withdrawal
Fields
- Author
- Gust, S.W.
- Hughes, J.R.
- Pechacek, T.F.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Master ID
- 2046398862/0490
- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
Related Documents:
Document Images
I
I
I
I
I
I
I
I
I
I
I
I
I
I
a
I
I
I
PreTalence of Tobacco Dependence and Withdrawal
John R. Hughes, M.ll., Steven W. Gust. Ph.D.. and TerrN F. Pechacek, Ph.D.
In a sample of1,0U6 middle-aged male smokers
drawn jrom the general population, 90% `\'=905)
julfilled DSM-III criteria and 36% (N=362) fulfilled
Fagerstrom's crrteria ror tobacco dependence. Among
the 875 who had stopped smoking in the past for at
least 24 hours, 21 %(N=184) fulfilled DSM-III
criteria and 46% (N=403) ful ftlled the authors' own
criteria for tobacco withdrawal. Concordance of
results among the criteria for diagnosing tobacco
dependence and withdrawal was low. These results
suggest that the DSM-III criteria for tobacco
dependence are overinclusive and that there is little
consensus among the definitions of tobacco
dependence and withdrawal.
(Am J Psychiatry 1987; 144:205-208)
R esearchers in the National Institute of Mental
Health's Epidemiologic Catchment Area Program
reported that the 6-month prevalence of drug depen-
dence in the United States is less than 10% (1, 2).
However, this survey omitted two common substance
use disorders: tobacco dependence and tobacco with-
drawal. Tobacco dependence is defined by DSM-111
(pp. 176-178) as 1) continuous use of tobacco for at
least 1 month plus 2) either unsuccessful attempts to
abstain, development of tobacco withdrawal symp-
toms, or continued use of tobacco despite having a
tobacco-induced illness. Tobacco withdrawal is de-
fined by DSM-III (pp. 159-160) as use of more than
10 cigarettes per day that contain at least 0.5 mg of
nicotine and occurrence of at IPzst four of the follow-
ing within 24 hours of stopping smoking: craving for
tobacco, irritability, anxiety, difficulty concentrating,
restlessness, headache, drowsiness, and gastrointesti-
nal disturbances.
Presented at the 47th annual meeting of the Committee on
Problems of Drug Dependence. Baltimore, Md., June 1984. Re-
ceived Jan. 8, 1986; revised May 5, 1986; accepted June 30. 1986.
From the Departments of Psvchiatrv and Epidemiologv, University
ot Minnesota, Minneapolis. Address reprint requests to Dr. Hughes,
Behavioral Medicine Service. Department of Psvchiatry, Universitv
of Vermont College of Medicme, Burlington, VT 05405.
Supported by grants DA-02239, DA-02298, DA-03728, and
DA-04066 and a Research Scientist Development Award
(DA-00109) to Dr. Hughes trom the National [nsntate on Drug
Abuse and by funds for psychiatric research from the State of
.Minnesota.
Copyright C 1987 American Psychiatric Association.
Am J Psychiatry 144:2, February 1987
Thirtr-three percent of Americans smoke (3). The
proportion of these smokers who are tobacco depen-
dent or experience withdrawal is virtually unknown
i4). The few previous studies of the prevalence of
tobacco dependence and withdrawal used select pop-
ulations (e.g., patients in smoking-cessation clinics)
and unvalidated criteria (5); thus, the generalizability
and validitv of their results can be questioned.
Knowledge of the prevalence of tobacco dependence
is important for at least three reasons. First, several
recent advances in dependence-based treatments for
smoking appear to be effective, e.g., nicotine gum (6),
clonidine (7), and brand fading (8). Knowledge of the
prevalence of tobacco dependence and withdrawal
would help determine the proportion of smokers who
might benefit from such treatments. Second, smokers
who attend formal treatment programs are usually
dependent on tobacco (9). Knowledge of the preva-
lence of tobacco dependence would help anticipate the
need for such smoking-cessation programs. Finally,
indirect evidence suggests that the smokers who have
quit aie the less dependent smokers (10). If this
selection bias continues, then future populations of
smokers should contain higher proportions of depen-
dent smokers. Serial determinations of the prevalence
of tobacco dependence and withdrawal are necessary
to test this hypothesis.
For these reasons, we surveyed the prevalence of
tobacco dependence and withdrawal, defined accord-
ing to accepted criteria, in a population-based sample.
METHOD
In 1974-1975, 116,980 households in defined cen-
sus blocks in the Minneapolis-St. Paul metropolitan
area were screened to find subjects to participate in the
Multiple Risk Factor Intervention Trial (11). From
these households, 30,401 men were screened, but only
703 men were entered into the trial. In 1980. we
randomly sampled 5,000 of the households that con-
tained ineligible men and found 1,184 men who were
smokers and were willing to be in a study. After they
gave informed consent, these men were randomly
divided into four groups, each of which was given
some combination of mailings, phone calls, and book-
lets about smoking and brief annual clinic visits. At the
2-year follow-up, 1,006 men were located, and they
completed the survey that was the basis for this report.
205

;c?if1(t!,M rt~l t1(!. t\l)\11711OR.?1~ 11
I
I
I
I
I
I
I
I
I
I
I
I
I
I
1
I
I
At this r(>IIMt'-UP. h.y '. ~=t~`1 r tht' ,UnleLts hSJ
stoppeci ~me~Kin1-1. ~tncr thr t~~:r~XnracC Or rn0,c Whc~
,topped did not Jitter across the tour groups, data
trom 111 5ublects were used in this anal~-s(s.
To determine the prevalence ot tobacco dependence
and ~~ lthdraw sl. %~c questl(~ns on ti;L:
DSM-III criteria as well as the criteria proposed by
Fagerstrom ; 1 2; tor tobacco dependence and our own
criteria for tobacco withdrawal 13). We chose the
latter two sets ot criteria because, unlike most depen-
dence and withdra%val criteria, they have been well
validated ;4, 12, 13). The Fagerstrom criteria tor
tobacco dependence include 1) the number of ciga-
rettes smoked per day, 2) the number of milligrams of
nicotine in each cigarette, 3) whether the smoker
inhales. 4) whether the subject smokes more in the
morning than in the afternoon and evening, 5) whether
the subject smokes upon arising, 6) whether the first
cigarette of the day is the most desirable, 7) whether it
is difficult to refrain temporarily from smoking, and 8)
whether the smoker smokes when ill. Our own criteria
for tobacco withdrawal require the presence of at least
four of the following in a smoker who has stopped for
more than 24 hours: the first five of the DSM-III
withdrawal s,vmptoms, whic;-L we have already listed,
plus increased appetite, impatience, somatic com-
plaints (headache, dizziness, tremor, stomach or bowel
problems), and insomnia.
RESULTS
The mean±SD age of the subjects was 51.1'_-6.4
years. Ninety percent (N=905) had completed high
school, 58% (N=583) were professionals (occupa-
tional classes I-[II) ' 14), and 46% (N=463) earned at
least S30,000 a year. The mean-SD number of ciga-
rettes they smoked per day was 28.0± 12.8, the mean-
SD amount of nicotine per cigarette was 0.9-0.4 mg,
and the mean=SD number of years they had smoked
was 33.0±7.1. Forty-two percent (N=423) had tried
to quit at least three times. These smoking habits are
almost identical to those reported in previous surveys
of middle-aged men (3) and, in fact, are quite similar to
those obtained in survevs of all U.S. adults ;3).
Ninety percent (N=905) of the smokers fulfilled
DSM-111 criteria for tobacco dependence. Sixty-one
percent (N=614) had made an unsuccessful attempt to
stop smoking, 21% (N=211) experienced tobacco
withdrawal symptoms, and 23% (N=231) continued
to smoke despite physical illness caused by smoking.
Thirty-six percent (N=362) of the smokers fulfilled
Fagerstrom's criteria for tobacco dependence (see table
1). The most prevalent DSM-III criterion was unsuc-
cessful attempts to quit. Inhaling and smoking on
arising were the most prevalent Fagerstrom criteria.
Eighty-seven percent (N=875) of the smokers re-
ported that they had stopped smoking for at least 24
hours in the past. The mean=SD length of time since
they had last quit for at least 24 hours was 67±86
TABLE 1. Prevaience of Tobacco Dependence According to the
Fagerstrom Criteria in 1.006 Smokers
i
< Score=() Score=! Score=2
.riterton ane
Meth o1 ot Scornnc N °~ N . N %
\.;,e1t,Cr ~;r , li;.trettC, tnoi:eJ :iaY
3av ;.15=n, h-'3=1. -25='
181
l5 3U1
.30
523 52
\fc nr nicnttne rer :ti_arerte
u.y=u, u.y-1, = 1. ..1.2='
.i4.3
54 312
31
151 15
(nhale nevcr=u, ,umenmes= l,
alwavs=21
20
2 30
3
956 95
Smoke more in a.m. than fl.m.
no=(1. ves= 1
453
45 553
55
5moke upon snstnl: <30 minutes
=U. >30 minutes=ll
332
33 674
67
`lost destrabie ~tc.uerte
,others=U. tirst one= 1,
885
88 121
12
Difficult to retrain
temporarily (no=O, yes= t)
875
87 131
13
Smoke when ill (no=0, yes=1) 573 57 433 43
'A score of more than 7 is required for a diagnosis of tobacco
dependence.
months. The mean=SD duration of the last attempt to
stop was 69± 139 days. Ninety-three percent (N=814)
quit abruptly. Ninety-six percent (N=840) stated that
their memory of withdrawal symptoms was accurate.
The self-reported accuracy of withdrawal symptoms
and the number of withdrawal symptoms were not
associated with the length of time since they had last
stopped or the duration of the last period of nonsmok-
ing.
Among those who had quit at some time, 21%
(N=184) fulfilled DSM-111 criteria and 46% (N=403)
fulfilled our criteria for tobacco withdrawal (see table
2). The corresponding rates for all smokers (quitters
and nonquitters) were 18% (N=181) and 37% (N=
372). Craving for tobacco, restlessness, increased ap-
petite, and impatience were the most common with-
drawal symptoms.
The DSM-111 definition of tobacco dependence was
not concordant with the Fagerstrom definition of
tobacco dependence or with either definition of to-
bacco withdrawal (tc<.04) (15). The Fagerstrom defi-
nition of tobacco dependence was modestly concor-
dant with both definitions of tobacco withdrawal
(K=.23 and .16 for DSM-111's and our definition,
respectively. The DSM-111 definition of withdrawal
and our definition of withdrawal were fairly concor-
dant (K=.44).
DISCUSSION
The different definitions of tobacco dependence and
withdrawal produced very different prevalence rates_ ~
and showed little concordance. One possible reason ~
for this lack of agreement is that one or more of the ~
definitions are invalid. We know of no tests of the.~
validity of the DSM-111 definition of tobacco depen- ~
dence. In addition, the fact that this definition classi- ~
fied 90% of the tobacco users in this study as depen- ~
F-i
~ 206 Am J Psychiatry 144:2, February 1987

1
1
I
I
I
I
I
I
I
I
I
I
I
I
iABLE 2. Prevafertee of Tooacca Jvithorawat Symptoms in 875
Smokers Who Had Zit Smokin¢ in the Past
t rireril
~
' ~ kI -111
;',ed cciba~:,:c, ror a: iea,t sr%rr.ii xcrh.
"mc Kr:i mctrr tnan I'l 1IL'1rc.^.C, i J.it
l.icarette cc ntatned more tnan t+ ~ me ut n,;omtit
.~t le.ist tour < t tnr tc,lluH int imin _'-1 iiuurl
,t stopping smokine
- I
~iu
.a
Craving tor tobacco h39
Irntabtlitv 324
Anxtetv 368 42
Dtfficuln, concentrating
193
Restlessness
Headache 438
26 ;n
3
Drowsiness -0 8
Gastrointestinal disturbances ?6 3
authors' own criteria: at least four of the following
~ctrhtn 24 hours of stopping smoking
Craving for tobacco
639
3
;
Irritability 324
Anxtetv 368
Dtfficultv concentrating 193
Restlessness 438 5 0
Increased appetite 420 48
Impatience 411 4 7
Somatic complaints 166 19
Insomnia '9 9
dent suggests that it is overinclusive and thus may lack
diagnostic discriminabilitv. The only validity test of
the DSM-111 definition of tobacco withdrawal that we
know of found that three of the eight symptoms did
not occur upon cissation of smoking (13).
On the other hand, several controlled, prospective
studies have tested the validity of the Fagerstrom
definition of tobacco dependence and of our definition
of tobacco withdrawal (e.g., 4, 6, 9, 10). Of the 11
rests of the Fagerstrom definition of dependence. most
have found that it predicts tolerance, withdrawal,
smoking to obtain nicotine, relapse, and, most impor-
rantly, therapeutic response to nicotine gum ;-+). Like-
wise, seven studies (e.g., 4, 13. 16) have found that our
own criteria for tobacco withdrawal are reliable, valid,
and sensitive to both abstinence from tobacco and
relief by nicotine gum. For these reasons, we believe
that the prevalence rates given by the Fagerstrom
definition of tobacco dependence and our definition of
tobacco withdrawal are valid and conservative first
approximations, whereas those calculated from the
DSM-!II criteria may not be valid.
According to Fagerstrom's and our definitions, one-
third of smokers are either behaviorally dependent or
physically dependent on tobacco (i.e., experience with-
drawal symptoms). Since one-third of Americans
smoke, approximately one in 10 Americans is pres-
ently tobacco dependent, according to our results. In
comparison, no psychiatric diagnosis was present in
more than 10% of the population in the Epidemiologic
Catchment Area Program reports (1, 2).
Our results must be considered preliminary, as the
generalizabiliry and validity of our data can be ques-
tioned. The generalizability is uncertain because we
Am J Psychiatry 144:2, February 1987
' It (,1IE'.S. ('l 5T. .1\D I'E.C.HAc.E.f:
ur~<<eu on" mtdcile-,iUeci male smokers. Although
~i;uat;:)n ,; c.ur prC~.1ICnCL ' raCc's t11 uthCr agC antj ~CX
"'roups ts ccrtatnlv needed, previous studies ;e.g., 5. 13)
nave round that az;c and sex have little or no effect on
;c)baucc~ Licpendence and wtthdrawal.
1-he %sliciitv w'c)ur r',ttmates of tobacco withdra«al
~an be questioned tor at least two reasons. First. our
sata are based on retrospective self-reports. However,
the large majortty ot our smokers stated that their
memory was accurate. More important, the time since
the subjects had last quit smoking was not associated
with an increase or decrease in the number of with-
drawai symptoms thev reported. Second, we decided
to require that a smoker must have stopped smoking
for at least 24 hours for withdrawal to be assessed. We
made this rule to exclude halfhearted, temporary, or
environmentally induced periods of abstinence. Also,
many of the symptoms of withdrawal (e.g., insomnia)
are not evident until several hours after cessation (5).
However, our rule may have biased the results if it
excluded smokers who had such severe withdrawal
that they could not remain abstinent for 24 hours. We
reasoned that, if anything, the rule would produce an
underestimate of the prevalence of withdrawal.
In conclusion, our data indicate that many, but not
all, smokers are behaviorally or physically dependent
on tobacco. This result suggests that a considerable
minority (20%-50%) of smokers may benefit from
formal treatment programs or dependence-based treat-
ments. Our data also indicate that the DSM-III criteria
for tobacco dependence are overinclusive and are not
concordant with other measures of tobacco depen-
dence and withdrawal. These results suggest that the
DSM-111 criteria for tobacco dependence need to be
reformulated.
REFERENCES
1. Jtvers JK, Weissman Tischler GL, et al: Six-month
prevalence of psychiatric disorders in three communities. Arch
Gen Psvchtatrv 1984: 41:959-967
'_. Blazer D, George LK, Landerman R, et al: Psychiatric disorders:
a ruraliurban comparison. Arch Gen Psychiatry 1985; 42:651-
656
3. Smoking and Health-A Report of the Surgeon General:
DHEW Publication PHS ?9-5066. Washington, DC, US Gov-
ernment Printing Office. 1979
4. Hughes JR: Identttication ot the dependent smoker: validity and
clinical utility. Behavioral Medicine Abstracts 1984; 5:202-204
:. Shiffman S.I~t: The tobacco withdrawal syndrome, in Cigarette
Smoking as a Dependence Process, NIDA Research Monograph
23: DHEW Publication ADM 79-800. Edited by Krasnegor
NA. Washington. DC, US Government Printing O,ffice, 1979
6. Hughes JR. Miller SA: Nicotine gum to help stop smoking.
JAMA 1984; 252:2855-2858
-. Glassman AH, Jackson WK, Walsh BT, et al: Cigarette craving,
smoking withdrawal, and clonidine. Science 1984; 26:864-866
8. Prue DIM, Kraptl JE, Martin JE: Brand fading: the effects of
gradual changes to low tar and nicotine cigarettes on smoking
rate, carbon monoxide, and thiocyanate levels. Behavior Ther-
apist 1981; 12:400-416
9. Russell MAH, Peto J, Patel UA: The dassification of smoking by
factorial structure of motives. J Royal Statistical Society, Series
A, 1974; 137:313-333
10. Pechacek TF: Modification of smoking behavior, in Smoking
207

I
I
I
I
i
I
I
I
I
I
I
I
I
I
I
I
I
K(Sf: E 1C IOk~ FOK .AtURT.AI 1 ; Y
1nd Hr.tltii- \ Rcnc~r; w ~. , eL:un t,c nrr. i!11 IF,\t. I'-rii-
-inon I'H'~ ',7- \\ i., Pc . rrnrnent i'rint
mc Om". I y-y
I l. \lultiPlr Kuk Facror In;cn. .: m Iri.ri Rrse.tr,h (,n ut,: .\lul-
npie Ri~k I-.tctt:r Intenc,.: -.u: Ri.,
mortltuts re.ultti. I\NI \ I~'. _ut l~h -i}-- hanLe. .rns Ii.
1'_. Fat;erstrom ;;-U: \teasunnu .:urcr t I i a.u ie{%nuen,r tt) 1 h.
tobacco dependence with rererence to indr.icluaiiwuon ot treac-
ment. Addict Behav 1978; 3:'_33-2-41
I~. Hupneti f R. Hanukami I): ~iUns .tnci ~~ mptomti ur ;nha
ccirhdr.t«a;. .\rch (,en P.~chi.ur% iaNh: -1;:289-294
14. Hullint_,neau Ali. Redlich F{: Social (:lass and Mental lllnec,
\ Commumn ticudc. New YF,rk. /ohn Wiley & Sons, l9iss
U)hen I: .-\ xemcrent ot aareement tctr nominal scales. Edura.
n mal ana Psvcholc~xical ~teasurement lN6t); 2U:37--tb
HuLhc, i R. H.irsukami DK. Pickens R\C'. er al: Effect ot niconnc
rn the te bacco «,rhd,awal +vndrome. PsvehopharmacoiuQ%
Berlin 1984; K.3:82-87
1 208 Am J Psychietry 144:2, February 1987
